Want to track PRQR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ProQR Therapeutics N.V. (PRQR) Statistics
Valuation metrics
Market Cap 207.46M
Enterprise value 103.35M
Trailing P/E (ttm) -3.73
Forward P/E -3.69
PEG ratio 0.13
Price/Sales (ttm) 12.67
Price/Book (mrq) 4.54
Enterprise Value/Revenue 7.66
Enterprise Value/EBITDA -2.53
Overview
Shares outstanding 105.36M
Float 64.35M
Shares short 1.67M
% Held by insiders 0.18%
% Held by institutions 0.51%
Average volume (10 days) 490.42K
Average volume (90 days) 827.75K
Price summary
52-Week low 1.33
52-Week high 3.1
Beta 0.09
50-Day moving average 1.74
200-Day moving average 1.64
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -3.39%
Operating margin -3.45%
Operational effectiveness
Return on assets -0.46%
Return on equity -0.87%
Income Statement
Revenue (ttm) 19.27M
Revenue per share (ttm) 0.13
Quarterly revenue growth (yoy) 0.06%
Gross profit (ttm) 19.27M
EBITDA -50.14M
Net income to common (ttm) -49.72M
Diluted EPS (ttm) -0.43
Quarterly earnings growth (yoy) 0.09%
Balance Sheet
Total cash (mrq) 108.91M
Total cash per share (mrq) 0.77
Total debt (mrq) 18.81M
Total Debt/Equity (mrq) 0.36
Current ratio (mrq) 2.48%
Book value per share (mrq) 0.36
Cash Flow
Cash flow statement -62.22M
Levered free cash flow (LFCF) -37.76M
